$ENOV
Enovis CORP

2023 Q2 Form 10-Q Financial Statement

#000142080023000014 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $428.5M $406.2M
YoY Change -58.13%
Cost Of Revenue $180.1M $171.1M
YoY Change -69.63%
Gross Profit $248.4M $235.1M
YoY Change -42.27%
Gross Profit Margin 57.96% 57.88%
Selling, General & Admin $193.4M $207.2M
YoY Change -47.63%
% of Gross Profit 77.89% 88.13%
Research & Development $18.92M $18.19M
YoY Change -22.47%
% of Gross Profit 7.62% 7.74%
Depreciation & Amortization $53.04M $51.99M
YoY Change -19.66%
% of Gross Profit 21.36% 22.12%
Operating Expenses $244.6M $225.4M
YoY Change -37.88%
Operating Profit $3.743M -$24.97M
YoY Change -92.95%
Interest Expense -$4.076M $5.652M
YoY Change -127.0%
% of Operating Profit -108.9%
Other Income/Expense, Net -$753.0K $661.0K
YoY Change
Pretax Income -$19.32M -$29.96M
YoY Change -150.82%
Income Tax -$4.713M -$7.100M
% Of Pretax Income
Net Earnings -$9.995M -$23.35M
YoY Change -161.32%
Net Earnings / Revenue -2.33% -5.75%
Basic Earnings Per Share -$0.18 -$0.43
Diluted Earnings Per Share -$0.18 -$0.43
COMMON SHARES
Basic Shares Outstanding 54.50M shares 54.33M shares
Diluted Shares Outstanding 54.51M shares 54.33M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.49M $21.90M
YoY Change -95.09%
Cash & Equivalents $32.49M $21.90M
Short-Term Investments
Other Short-Term Assets $101.9M $61.02M
YoY Change 11.28%
Inventory $453.9M $439.0M
Prepaid Expenses $26.76M $30.49M
Receivables $299.0M $280.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $887.2M $833.1M
YoY Change -62.21%
LONG-TERM ASSETS
Property, Plant & Equipment $322.5M $246.0M
YoY Change -36.09%
Goodwill $2.034B $1.987B
YoY Change -40.88%
Intangibles $1.111B $1.082B
YoY Change -32.15%
Long-Term Investments
YoY Change
Other Assets $88.78M $87.87M
YoY Change -76.31%
Total Long-Term Assets $3.556B $3.466B
YoY Change -42.04%
TOTAL ASSETS
Total Short-Term Assets $887.2M $833.1M
Total Long-Term Assets $3.556B $3.466B
Total Assets $4.444B $4.300B
YoY Change -47.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $147.2M $151.7M
YoY Change -72.63%
Accrued Expenses $182.2M $197.8M
YoY Change -62.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $353.7M $349.5M
YoY Change -75.61%
LONG-TERM LIABILITIES
Long-Term Debt $400.0M $285.0M
YoY Change -75.73%
Other Long-Term Liabilities $239.1M $170.5M
YoY Change -60.21%
Total Long-Term Liabilities $639.1M $455.5M
YoY Change -71.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $353.7M $349.5M
Total Long-Term Liabilities $639.1M $455.5M
Total Liabilities $994.9M $854.3M
YoY Change -74.09%
SHAREHOLDERS EQUITY
Retained Earnings $542.4M $552.4M
YoY Change -10.21%
Common Stock $55.00K $54.00K
YoY Change 1.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.449B $3.443B
YoY Change
Total Liabilities & Shareholders Equity $4.444B $4.300B
YoY Change -47.62%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$9.995M -$23.35M
YoY Change -161.32%
Depreciation, Depletion And Amortization $53.04M $51.99M
YoY Change -19.66%
Cash From Operating Activities $28.10M $7.457M
YoY Change -294.85%
INVESTING ACTIVITIES
Capital Expenditures $36.81M $30.44M
YoY Change 52.79%
Acquisitions $3.942M
YoY Change
Other Investing Activities -$94.80M -$3.942M
YoY Change 755.81%
Cash From Investing Activities -$131.6M -$34.39M
YoY Change 274.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 114.2M $24.50M
YoY Change -1155.67%
NET CHANGE
Cash From Operating Activities 28.10M $7.457M
Cash From Investing Activities -131.6M -$34.39M
Cash From Financing Activities 114.2M $24.50M
Net Change In Cash 10.71M -$2.395M
YoY Change -118.51%
FREE CASH FLOW
Cash From Operating Activities $28.10M $7.457M
Capital Expenditures $36.81M $30.44M
Free Cash Flow -$8.702M -$22.99M
YoY Change -77.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Enovis CORP
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001420800
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34045
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
54-1887631
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2711 Centerville Road,
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19808
CY2023Q1 dei City Area Code
CityAreaCode
(302)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
252-9160
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
ENOV
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54496415 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
406151000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375457000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
171086000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
169557000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
235065000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
205900000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
207165000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
188480000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18193000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14842000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32040000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30786000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
2635000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
2419000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-24968000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-30627000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
5652000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
7064000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
661000 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29959000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37691000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7113000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
364000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-22846000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-38055000 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-312000 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
54356000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-23158000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
192000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
267000 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
966000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-23350000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
15068000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.42
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.42
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.71
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.71
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.99
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.99
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21900000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24295000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8063000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7965000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
280748000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
267380000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
438957000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
426643000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30487000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28550000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
61018000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
48155000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
833110000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
795023000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
245989000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
236741000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
1987222000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
1983588000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1081801000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1110727000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63590000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66881000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
87874000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80288000 usd
CY2023Q1 us-gaap Assets
Assets
4299586000 usd
CY2022Q4 us-gaap Assets
Assets
4273248000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
219279000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
151743000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
135628000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
197754000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
210292000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
349497000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
565199000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
285000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40000000 usd
CY2023Q1 cfx Operating Lease Liability Present Value Noncurrent
OperatingLeaseLiabilityPresentValueNoncurrent
49293000 usd
CY2022Q4 cfx Operating Lease Liability Present Value Noncurrent
OperatingLeaseLiabilityPresentValueNoncurrent
51259000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
170525000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
166989000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
854315000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
823447000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
133333333 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
133333333 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54493154 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54493154 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54228619 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54228619 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
54000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
54000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2933773000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2925729000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
552382000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
575732000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-42870000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53430000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3443339000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3448085000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
1932000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1716000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3445271000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3449801000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4299586000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4273248000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-23158000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
338000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10584000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53461000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
2711000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
9028000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
199000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-629000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10584000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43804000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12574000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-27503000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
216000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
895000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12790000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28398000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3449801000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-23158000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10584000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8044000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3445271000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4661433000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
941000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3248000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43804000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11056000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4644045000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-23158000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16301000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51991000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66026000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7606000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
9857000 usd
CY2023Q1 cfx Noncashinterestexpense
Noncashinterestexpense
838000 usd
CY2022Q2 cfx Noncashinterestexpense
Noncashinterestexpense
978000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
831000 usd
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2232000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-429000 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-352000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12288000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20690000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9249000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
70830000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15621000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24713000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
25164000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
43362000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7457000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14423000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30443000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24089000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0 usd
CY2022Q2 us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
2746000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3942000 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13823000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34385000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35166000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
219468000 usd
CY2022Q2 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
250000000 usd
CY2022Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5672000 usd
CY2022Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7428000 usd
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
438000 usd
CY2022Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1199000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-800000 usd
CY2022Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4590000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24498000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10819000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2542000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2395000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57866000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24295000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
719370000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21900000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
661504000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q2 cfx Distribution Paid To Shareholders Separation Of Business
DistributionPaidToShareholdersSeparationOfBusiness
1200000000 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
52300000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements, and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.71
CY2022Q2 us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
18200000 usd
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
13600000 usd
CY2022Q2 us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
4600000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
21000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
406151000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375457000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.71
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
7965000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
528000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
463000 usd
CY2023Q1 cfx Financing Receivable Allowancefor Credit Loss Foreign Currency Translation1
FinancingReceivableAllowanceforCreditLossForeignCurrencyTranslation1
33000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
8063000 usd
CY2023Q1 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-23038000 usd
CY2022Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-38322000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54325396 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53872007 shares
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.42
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.42
CY2022Q4 cfx Tangible Equity Unit Initial Principal Amount
TangibleEquityUnitInitialPrincipalAmount
15.6099
CY2023Q1 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-23038000 usd
CY2022Q2 cfx Net Incomefromcontinuingoperationsattributableto Parent
NetIncomefromcontinuingoperationsattributabletoParent
-38322000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54325396 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53872007 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54325396 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53872007 shares
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.42
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.71
CY2023Q1 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
200000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
300000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1100000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2022Q2 cfx Other Comprehensive Income Loss Intra Entity Foreign Currency Translation Adjustment Adjustments Net Of Tax
OtherComprehensiveIncomeLossIntraEntityForeignCurrencyTranslationAdjustmentAdjustmentsNetOfTax
-15260000 usd
CY2022Q2 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
9028000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-44095000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7100000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37700000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000 usd
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.010 rate
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
10560000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
10560000 usd
CY2023Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10560000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-37863000 usd
CY2022Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-629000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-43466000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
100095000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
100038000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
33936000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
28164000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
363473000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
357143000 usd
CY2023Q1 us-gaap Inventory Gross
InventoryGross
497504000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
485345000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
58547000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
58702000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
438957000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
426643000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
285000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
259279000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
219279000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
285000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40000000 usd
CY2022Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
6003431 shares
CY2022Q4 cfx Interest Rateof Tangible Equity Notes
InterestRateofTangibleEquityNotes
0.0650
CY2022Q4 cfx Tangible Equity Unit Quarterly Cash Distribution
TangibleEquityUnitQuarterlyCashDistribution
1.4375
CY2022Q2 cfx Tangible Equity Unit Repayment
TangibleEquityUnitRepayment
6500000 usd
CY2023Q1 cfx Letters Of Credit And Surety Bonds Outstanding Amount
LettersOfCreditAndSuretyBondsOutstandingAmount
7100000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47252000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51384000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
16980000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
13676000 usd
CY2023Q1 cfx Accrued Freight
AccruedFreight
4155000 usd
CY2022Q4 cfx Accrued Freight
AccruedFreight
3955000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
7841000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8812000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2826000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2804000 usd
CY2023Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
944000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1090000 usd
CY2023Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
23945000 usd
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
24958000 usd
CY2023Q1 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
3919000 usd
CY2022Q4 cfx Customeradvancesandbillinginexcessofcostsincurred
Customeradvancesandbillinginexcessofcostsincurred
3560000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23116000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24281000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
599000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2921000 usd
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
7211000 usd
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
13715000 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
13708000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15670000 usd
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5996000 usd
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5777000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39262000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37689000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
197754000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
210292000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1091000 usd
CY2023Q1 cfx Restructuring Settlementand Impairment Provisionsbeforenoncashcharges
RestructuringSettlementandImpairmentProvisionsbeforenoncashcharges
2635000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
2782000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
944000 usd
CY2023Q1 cfx Noncashimpairmentrestructuringprovisions
Noncashimpairmentrestructuringprovisions
301000 usd
CY2023Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2936000 usd
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
285000000 usd
CY2023Q1 cfx Number Of Contingent Consideration Arrangements Unlimited Based On Percentage Of Sales In Excess Of Benchmark
NumberOfContingentConsiderationArrangementsUnlimitedBasedOnPercentageOfSalesInExcessOfBenchmark
2 contingentconsideration
CY2022Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
11696000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
406151000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
375457000 usd
CY2023Q1 cfx Segment Operating Income
SegmentOperatingIncome
56411000 usd
CY2022Q2 cfx Segment Operating Income
SegmentOperatingIncome
47727000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29959000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37691000 usd
CY2023Q1 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
2936000 usd
CY2022Q2 cfx Restructuring Chargesand Other Related Charges
RestructuringChargesandOtherRelatedCharges
2953000 usd
CY2023Q1 cfx Medical Device Regulations And Other Costs
MedicalDeviceRegulationsAndOtherCosts
7796000 usd
CY2022Q2 cfx Medical Device Regulations And Other Costs
MedicalDeviceRegulationsAndOtherCosts
2627000 usd
CY2023Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
11629000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6908000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6708000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
19951000 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
18500000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32040000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30786000 usd
CY2023Q1 cfx Inventory Adjustments Increase Decrease
InventoryAdjustmentsIncreaseDecrease
119000 usd
CY2022Q2 cfx Inventory Adjustments Increase Decrease
InventoryAdjustmentsIncreaseDecrease
5084000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
5652000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
7064000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
661000 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023Q1 cfx Segment Operating Income
SegmentOperatingIncome
56411000 usd
CY2022Q2 cfx Segment Operating Income
SegmentOperatingIncome
47727000 usd

Files In Submission

Name View Source Status
0001420800-23-000014-index-headers.html Edgar Link pending
0001420800-23-000014-index.html Edgar Link pending
0001420800-23-000014.txt Edgar Link pending
0001420800-23-000014-xbrl.zip Edgar Link pending
cfx-20230331.htm Edgar Link pending
cfx-20230331.xsd Edgar Link pending
exhibit311ceocertification.htm Edgar Link pending
exhibit312cfocertification.htm Edgar Link pending
exhibit321ceocertification.htm Edgar Link pending
exhibit322cfocertification.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
cfx-20230331_def.xml Edgar Link unprocessable
cfx-20230331_cal.xml Edgar Link unprocessable
cfx-20230331_lab.xml Edgar Link unprocessable
cfx-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cfx-20230331_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending